{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:23:49Z","timestamp":1792268629229,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:00:00Z","timestamp":1707782400000},"content-version":"vor","delay-in-days":43,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ghadvances.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastro Hep Advances"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.gastha.2024.02.003","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T18:03:44Z","timestamp":1708106624000},"page":"491-497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["First-in-Human Assessment of Gut Permeability in Crohn\u2019s Disease Patients Using Fluorophore Technology"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5591-7794","authenticated-orcid":false,"given":"Lori R.","family":"Holtz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Darren","family":"Nix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sewuese E.","family":"Akuse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Hall-Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney D.","family":"Newberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Ciorba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parakkal","family":"Deepak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Zulfiqar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeng-Jong","family":"Shieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. Rochelle","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Dorshow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.gastha.2024.02.003_bib1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MCO.0000000000000778","article-title":"What is the leaky gut? Clinical considerations in humans","volume":"24","author":"Camilleri","year":"2021","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"Suppl 4","key":"10.1016\/j.gastha.2024.02.003_bib2","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1093\/cid\/ciu541","article-title":"Use of the lactulose to mannitol ratio to evaluate childhood environmental enteric dysfunction: a systematic review","volume":"59","author":"Denno","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.gastha.2024.02.003_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.874116","article-title":"Rhamnose is superior to mannitol as a monosaccharide in the dual sugar absorption test: a prospective randomized study in children with treatment-naive celiac disease","volume":"10","author":"Holtz","year":"2022","journal-title":"Front Pediatr"},{"issue":"1","key":"10.1016\/j.gastha.2024.02.003_bib4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12876-021-02082-z","article-title":"A\u00a0case for improved assessment of gut permeability: a meta-analysis quantifying the lactulose:mannitol ratio in coeliac and Crohn's disease","volume":"22","author":"Gan","year":"2022","journal-title":"BMC Gastroenterol"},{"issue":"Suppl 3","key":"10.1016\/j.gastha.2024.02.003_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2036.1997.tb00808.x","article-title":"Review article: intestinal permeability in Crohn's disease","volume":"11","author":"Meddings","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.gastha.2024.02.003_bib6","first-page":"456","article-title":"Increased intestinal permeability in patients with inflammatory bowel disease","volume":"9","author":"Welcker","year":"2004","journal-title":"Eur J Med Res"},{"issue":"6","key":"10.1016\/j.gastha.2024.02.003_bib7","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0022-3476(98)70145-3","article-title":"The sugar permeability test reflects disease activity in children and adolescents with inflammatory bowel disease","volume":"133","author":"Miki","year":"1998","journal-title":"J\u00a0Pediatr"},{"issue":"6","key":"10.1016\/j.gastha.2024.02.003_bib8","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1053\/j.gastro.2020.08.005","article-title":"Increased intestinal permeability is associated with later development of crohn's disease","volume":"159","author":"Turpin","year":"2020","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.gastha.2024.02.003_bib9","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1136\/gutjnl-2022-328421","article-title":"Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn's disease highlight earliest events of pathogenesis","volume":"72","author":"Leibovitzh","year":"2023","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.gastha.2024.02.003_bib10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1053\/j.gastro.2022.10.014","article-title":"Intestinal barrier healing is superior to endoscopic and histologic remission for predicting major adverse outcomes in inflammatory bowel disease: the prospective ERIca trial","volume":"164","author":"Rath","year":"2023","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.gastha.2024.02.003_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-09971-y","article-title":"Measurement of gut permeability using fluorescent tracer agent technology","volume":"7","author":"Dorshow","year":"2017","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.gastha.2024.02.003_bib12","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1364\/BOE.10.005103","article-title":"Transdermal fluorescence detection of a dual fluorophore system for noninvasive point-of-care gastrointestinal permeability measurement","volume":"10","author":"Dorshow","year":"2019","journal-title":"Biomed Opt Express"},{"issue":"8","key":"10.1016\/j.gastha.2024.02.003_bib13","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1177\/1535370218768508","article-title":"EB 2017 Article: interpretation of the lactulose:mannitol test in rural Malawian children at risk for perturbations in intestinal permeability","volume":"243","author":"Ordiz","year":"2018","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.gastha.2024.02.003_bib17","series-title":"Clinical results from a pilot multi-center study using a novel fluorescent tracer agent for renal function measurement","author":"Dorshow","year":"2023"},{"issue":"2","key":"10.1016\/j.gastha.2024.02.003_bib18","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.xphs.2019.11.002","article-title":"Characterization of MB-102, a new fluorescent tracer agent for point-of-care renal function monitoring","volume":"109","author":"Shieh","year":"2020","journal-title":"J\u00a0Pharm Sci"},{"issue":"1","key":"10.1016\/j.gastha.2024.02.003_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.yrtph.2015.02.018","article-title":"Pre-clinical toxicity evaluation of MB-102, a novel fluorescent tracer agent for real-time measurement of glomerular filtration rate","volume":"72","author":"Bugaj","year":"2015","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.gastha.2024.02.003_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2019.104417","article-title":"Next tier in\u00a0vitro and in\u00a0vivo nonclinical studies further elucidating the safety and toxicity profile of MB-102, a novel fluorescent tracer agent for measurement of glomerular filtration rate","volume":"107","author":"Dorshow","year":"2019","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.gastha.2024.02.003_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2022.105158","article-title":"Absence of developmental or reproductive toxicity in rats for MB-102, a fluorescent tracer agent for point-of-care measurement of glomerular filtration rate","volume":"131","author":"Bugaj","year":"2022","journal-title":"Regul Toxicol Pharmacol"},{"issue":"5","key":"10.1016\/j.gastha.2024.02.003_bib22","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1177\/10915818221111331","article-title":"Evaluation of developmental and reproductive toxicity in rabbits for MB-102, a fluorescent tracer agent designed for real-time measurement of glomerular filtration rate","volume":"41","author":"Bugaj","year":"2022","journal-title":"Int J Toxicol"},{"issue":"9","key":"10.1016\/j.gastha.2024.02.003_bib23","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"20","key":"10.1016\/j.gastha.2024.02.003_bib24","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1039\/C8AY00576A","article-title":"Clinical analysis and quantitation of MB-102, a novel fluorescence tracer agent, in human plasma","volume":"10","author":"Shieh","year":"2018","journal-title":"Anal Methods"},{"issue":"1","key":"10.1016\/j.gastha.2024.02.003_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2016-000066","article-title":"Improving the detection of environmental enteric dysfunction: a lactulose, rhamnose assay of intestinal permeability in children aged under 5 years exposed to poor sanitation and hygiene","volume":"1","author":"Faubion","year":"2016","journal-title":"BMJ Glob Health"},{"issue":"2","key":"10.1016\/j.gastha.2024.02.003_bib26","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1053\/j.gastro.2019.03.051","article-title":"Development and validation of a simplified magnetic resonance index of activity for crohn's disease","volume":"157","author":"Ordas","year":"2019","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.gastha.2024.02.003_bib27","first-page":"767","article-title":"Intestinal permeability to 99mTc-diethylenetriaminopentaacetic acid in inflammatory bowel disease","volume":"81","author":"Casellas","year":"1986","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.gastha.2024.02.003_bib28","doi-asserted-by":"crossref","first-page":"G919","DOI":"10.1152\/ajpgi.00168.2011","article-title":"Urine sugars for in\u00a0vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls","volume":"301","author":"Rao","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"8","key":"10.1016\/j.gastha.2024.02.003_bib29","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1111\/j.1572-0241.2002.05914.x","article-title":"Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease","volume":"97","author":"Suenaert","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.gastha.2024.02.003_bib30","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.crohns.2011.10.004","article-title":"Anti-TNF-alpha antibodies improve intestinal barrier function in Crohn's disease","volume":"6","author":"Noth","year":"2012","journal-title":"J\u00a0Crohns Colitis"},{"issue":"3","key":"10.1016\/j.gastha.2024.02.003_bib31","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1053\/j.gastro.2017.05.056","article-title":"Impaired intestinal permeability contributes to ongoing bowel symptoms in patients with inflammatory bowel disease and mucosal healing","volume":"153","author":"Chang","year":"2017","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.gastha.2024.02.003_bib32","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1053\/j.gastro.2022.07.004","article-title":"Altered gut microbiome composition and function are associated with gut barrier dysfunction in healthy relatives of patients with crohn's disease","volume":"163","author":"Leibovitzh","year":"2022","journal-title":"Gastroenterology"}],"container-title":["Gastro Hep Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572324000232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572324000232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T09:14:00Z","timestamp":1716801240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772572324000232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"alternative-id":["S2772572324000232"],"URL":"https:\/\/doi.org\/10.1016\/j.gastha.2024.02.003","relation":{},"ISSN":["2772-5723"],"issn-type":[{"value":"2772-5723","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First-in-Human Assessment of Gut Permeability in Crohn\u2019s Disease Patients Using Fluorophore Technology","name":"articletitle","label":"Article Title"},{"value":"Gastro Hep Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastha.2024.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}